Form 4 Tracker
Aaron Kantoff

Director · 2 filings · Latest: Jun 2, 2026

Avalo Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AVTX
Aaron KantoffDirectorMar 28, 2026
Option Exercise
3,1666,333